Nancy Hong

Nancy Hong

Director/Board Member at
Sequre Dx, Inc.
Health Technology
Finance
Consumer Services

Profile

Dr. Nancy A. Hong is on the Board of Directors at Biolinq, Inc., Bluejay Therapeutics, Inc., Sequre Dx, Inc., Xilio Therapeutics LLC and Scout Bio, Inc. Dr. Hong was previously employed as a Managing Director by RiverVest Venture Management LLC, a Senior Associate by BioMed Ventures, a Principal by Novartis Institute for Functional Genomics, Inc., a Senior Analyst by Forward Ventures Services LLC, a Founder by Phenomix Corp., and a President by Archmont Biopharma, Inc. She also served on the board at Xilio Therapeutics, Inc. She received her undergraduate degree from California Institute of Technology and a doctorate degree from the University of California, Berkeley.

Nancy Hong active positions

CompaniesPositionStart
Director/Board Member 01/04/2021
Director/Board Member 01/09/2021
Director/Board Member 02/03/2020
Director/Board Member 01/06/2021
Director/Board Member 01/04/2019

Former positions of Nancy Hong

CompaniesPositionEnd
Private Equity Investor 01/09/2023
Corporate Officer/Principal 31/12/2009
Private Equity Analyst 31/12/2008
Corporate Officer/Principal 30/09/2006
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ -
See the detail of Nancy Hong's experience

Training of Nancy Hong

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

19

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Finance

Consumer Services

Consumer Services

Finance

Commercial Services

Finance

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!